Ontology type: schema:ScholarlyArticle
2019-07-18
AUTHORSMunemitsu Otagaki, Koichiro Matsumura, Hiromi Kin, Kenichi Fujii, Hiroki Shibutani, Hiroshi Matsumoto, Hiroki Takahashi, Haengnam Park, Yoshihiro Yamamoto, Tetsuro Sugiura, Ichiro Shiojima
ABSTRACTPurposeRecent studies have shown that sodium glucose cotransporter 2 (SGLT2) inhibitors have a favorable effect on cardiovascular events in diabetic patients. However, the underlying mechanism associated with a favorable outcome has not been clearly identified. The purpose of this study was to investigate the effect of tofogliflozin, SGLT2 inhibitor, on systolic and diastolic cardiac function in patients with type 2 diabetes mellitus (T2DM).MethodsWe enrolled 26 consecutive T2DM out-patients on glucose-lowering drugs who initiated tofogliflozin and underwent echocardiography before and ≥ 6 months after tofogliflozin administration. During this period, we also enrolled 162 T2DM out-patients taking other glucose-lowering drugs as a control group. Propensity score analysis was performed to match the patient characteristics. As a result, 42 patients (tofogliflozin group 21 patients and control group 21 patients) were finally used for analysis. Left ventricular systolic function was assessed by measuring 2D-echocardiographic left ventricular ejection fraction (LVEF) and diastolic cardiac function by pulsed wave Doppler-derived early diastolic velocity (E/e′).ResultsThere were no significant differences in patient characteristics and echocardiographic parameters at baseline. The change in LVEF from baseline to follow-up was 5.0 ± 6.9% in the tofogliflozin group and − 0.6 ± 5.5% in the control group; difference significant, p = 0.006. The change in E/e′ was − 1.7 ± 3.4 in the tofogliflozin group and 0.7 ± 4.1 in the control group; difference significant, p = 0.024.ConclusionsIn addition to conventional oral glucose-lowering drugs, additional tofogliflozin administration had a favorable effect on left ventricular systolic and diastolic function in patients with T2DM. More... »
PAGES435-442
http://scigraph.springernature.com/pub.10.1007/s10557-019-06892-y
DOIhttp://dx.doi.org/10.1007/s10557-019-06892-y
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1118091071
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/31321581
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Benzhydryl Compounds",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Diabetes Mellitus, Type 2",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Diastole",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Glucosides",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Myocardial Contraction",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Sodium-Glucose Transporter 2 Inhibitors",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Systole",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Cardiology, Kansai Medical University Medical Center, 10-15, Fumizono-cho, 570-8507, Moriguchi, Osaka, Japan",
"id": "http://www.grid.ac/institutes/grid.410783.9",
"name": [
"Department of Cardiology, Kansai Medical University Medical Center, 10-15, Fumizono-cho, 570-8507, Moriguchi, Osaka, Japan"
],
"type": "Organization"
},
"familyName": "Otagaki",
"givenName": "Munemitsu",
"id": "sg:person.012634224522.65",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012634224522.65"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Cardiology, Kansai Medical University Medical Center, 10-15, Fumizono-cho, 570-8507, Moriguchi, Osaka, Japan",
"id": "http://www.grid.ac/institutes/grid.410783.9",
"name": [
"Department of Cardiology, Kansai Medical University Medical Center, 10-15, Fumizono-cho, 570-8507, Moriguchi, Osaka, Japan"
],
"type": "Organization"
},
"familyName": "Matsumura",
"givenName": "Koichiro",
"id": "sg:person.011021307255.31",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011021307255.31"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Cardiology, Kansai Medical University Medical Center, 10-15, Fumizono-cho, 570-8507, Moriguchi, Osaka, Japan",
"id": "http://www.grid.ac/institutes/grid.410783.9",
"name": [
"Department of Cardiology, Kansai Medical University Medical Center, 10-15, Fumizono-cho, 570-8507, Moriguchi, Osaka, Japan"
],
"type": "Organization"
},
"familyName": "Kin",
"givenName": "Hiromi",
"id": "sg:person.012227342247.19",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012227342247.19"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Cardiology, Department of Medicine II, Kansai Medical University, Hirakata, Japan",
"id": "http://www.grid.ac/institutes/grid.410783.9",
"name": [
"Division of Cardiology, Department of Medicine II, Kansai Medical University, Hirakata, Japan"
],
"type": "Organization"
},
"familyName": "Fujii",
"givenName": "Kenichi",
"id": "sg:person.01164156601.70",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164156601.70"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Cardiology, Department of Medicine II, Kansai Medical University, Hirakata, Japan",
"id": "http://www.grid.ac/institutes/grid.410783.9",
"name": [
"Division of Cardiology, Department of Medicine II, Kansai Medical University, Hirakata, Japan"
],
"type": "Organization"
},
"familyName": "Shibutani",
"givenName": "Hiroki",
"id": "sg:person.01164134065.52",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164134065.52"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Cardiology, Kansai Medical University Medical Center, 10-15, Fumizono-cho, 570-8507, Moriguchi, Osaka, Japan",
"id": "http://www.grid.ac/institutes/grid.410783.9",
"name": [
"Department of Cardiology, Kansai Medical University Medical Center, 10-15, Fumizono-cho, 570-8507, Moriguchi, Osaka, Japan"
],
"type": "Organization"
},
"familyName": "Matsumoto",
"givenName": "Hiroshi",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Cardiology, Kansai Medical University Medical Center, 10-15, Fumizono-cho, 570-8507, Moriguchi, Osaka, Japan",
"id": "http://www.grid.ac/institutes/grid.410783.9",
"name": [
"Department of Cardiology, Kansai Medical University Medical Center, 10-15, Fumizono-cho, 570-8507, Moriguchi, Osaka, Japan"
],
"type": "Organization"
},
"familyName": "Takahashi",
"givenName": "Hiroki",
"id": "sg:person.013426706770.11",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013426706770.11"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Cardiology, Kansai Medical University Medical Center, 10-15, Fumizono-cho, 570-8507, Moriguchi, Osaka, Japan",
"id": "http://www.grid.ac/institutes/grid.410783.9",
"name": [
"Department of Cardiology, Kansai Medical University Medical Center, 10-15, Fumizono-cho, 570-8507, Moriguchi, Osaka, Japan"
],
"type": "Organization"
},
"familyName": "Park",
"givenName": "Haengnam",
"id": "sg:person.01252462647.18",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252462647.18"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Cardiology, Kansai Medical University Medical Center, 10-15, Fumizono-cho, 570-8507, Moriguchi, Osaka, Japan",
"id": "http://www.grid.ac/institutes/grid.410783.9",
"name": [
"Department of Cardiology, Kansai Medical University Medical Center, 10-15, Fumizono-cho, 570-8507, Moriguchi, Osaka, Japan"
],
"type": "Organization"
},
"familyName": "Yamamoto",
"givenName": "Yoshihiro",
"id": "sg:person.01366711247.60",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366711247.60"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Cardiology, Kansai Medical University Medical Center, 10-15, Fumizono-cho, 570-8507, Moriguchi, Osaka, Japan",
"id": "http://www.grid.ac/institutes/grid.410783.9",
"name": [
"Department of Cardiology, Kansai Medical University Medical Center, 10-15, Fumizono-cho, 570-8507, Moriguchi, Osaka, Japan"
],
"type": "Organization"
},
"familyName": "Sugiura",
"givenName": "Tetsuro",
"id": "sg:person.0706420742.40",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706420742.40"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Cardiology, Department of Medicine II, Kansai Medical University, Hirakata, Japan",
"id": "http://www.grid.ac/institutes/grid.410783.9",
"name": [
"Division of Cardiology, Department of Medicine II, Kansai Medical University, Hirakata, Japan"
],
"type": "Organization"
},
"familyName": "Shiojima",
"givenName": "Ichiro",
"id": "sg:person.0632605707.34",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632605707.34"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1186/s12933-018-0741-9",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1105411630",
"https://doi.org/10.1186/s12933-018-0741-9"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/s12933-018-0775-z",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1107488304",
"https://doi.org/10.1186/s12933-018-0775-z"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/s12933-017-0516-8",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1084251150",
"https://doi.org/10.1186/s12933-017-0516-8"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10557-017-6724-3",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1085052728",
"https://doi.org/10.1007/s10557-017-6724-3"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/s12933-018-0717-9",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1104147789",
"https://doi.org/10.1186/s12933-018-0717-9"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10557-017-6741-2",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1090851868",
"https://doi.org/10.1007/s10557-017-6741-2"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s12020-012-9623-1",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1015931238",
"https://doi.org/10.1007/s12020-012-9623-1"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/s12933-016-0489-z",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1013379554",
"https://doi.org/10.1186/s12933-016-0489-z"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10557-017-6734-1",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1086127767",
"https://doi.org/10.1007/s10557-017-6734-1"
],
"type": "CreativeWork"
}
],
"datePublished": "2019-07-18",
"datePublishedReg": "2019-07-18",
"description": "PurposeRecent studies have shown that sodium glucose cotransporter 2 (SGLT2) inhibitors have a favorable effect on cardiovascular events in diabetic patients. However, the underlying mechanism associated with a favorable outcome has not been clearly identified. The purpose of this study was to investigate the effect of tofogliflozin, SGLT2 inhibitor, on systolic and diastolic cardiac function in patients with type 2 diabetes mellitus (T2DM).MethodsWe enrolled 26 consecutive T2DM out-patients on glucose-lowering drugs who initiated tofogliflozin and underwent echocardiography before and \u2265\u20096\u00a0months after tofogliflozin administration. During this period, we also enrolled 162 T2DM out-patients taking other glucose-lowering drugs as a control group. Propensity score analysis was performed to match the patient characteristics. As a result, 42 patients (tofogliflozin group 21 patients and control group 21 patients) were finally used for analysis. Left ventricular systolic function was assessed by measuring 2D-echocardiographic left ventricular ejection fraction (LVEF) and diastolic cardiac function by pulsed wave Doppler-derived early diastolic velocity (E/e\u2032).ResultsThere were no significant differences in patient characteristics and echocardiographic parameters at baseline. The change in LVEF from baseline to follow-up was 5.0\u2009\u00b1\u20096.9% in the tofogliflozin group and \u2212\u20090.6\u2009\u00b1\u20095.5% in the control group; difference significant, p\u2009=\u20090.006. The change in E/e\u2032 was \u2212\u20091.7\u2009\u00b1\u20093.4 in the tofogliflozin group and 0.7\u2009\u00b1\u20094.1 in the control group; difference significant, p\u2009=\u20090.024.ConclusionsIn addition to conventional oral glucose-lowering drugs, additional tofogliflozin administration had a favorable effect on left ventricular systolic and diastolic function in patients with T2DM.",
"genre": "article",
"id": "sg:pub.10.1007/s10557-019-06892-y",
"inLanguage": "en",
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1097576",
"issn": [
"0920-3206",
"1573-7241"
],
"name": "Cardiovascular Drugs and Therapy",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "4",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "33"
}
],
"keywords": [
"left ventricular ejection fraction",
"diastolic cardiac function",
"glucose-lowering drugs",
"effects of tofogliflozin",
"cardiac function",
"control group",
"tofogliflozin administration",
"tofogliflozin group",
"diabetic patients",
"patient characteristics",
"sodium-glucose cotransporter 2 inhibitors",
"glucose cotransporter 2 inhibitors",
"oral glucose-lowering drugs",
"type 2 diabetic patients",
"left ventricular systolic function",
"type 2 diabetes mellitus",
"cotransporter 2 inhibitors",
"ventricular systolic function",
"ventricular ejection fraction",
"early diastolic velocity",
"left ventricular systolic",
"favorable effect",
"propensity score analysis",
"cardiovascular events",
"underwent echocardiography",
"echocardiographic parameters",
"ventricular systolic",
"systolic function",
"diastolic function",
"diabetes mellitus",
"ejection fraction",
"SGLT2 inhibitors",
"diastolic velocity",
"favorable outcome",
"PurposeRecent studies",
"patients",
"wave Doppler",
"T2DM",
"systolic",
"tofogliflozin",
"score analysis",
"drugs",
"underlying mechanism",
"significant differences",
"administration",
"baseline",
"group",
"inhibitors",
"mellitus",
"echocardiography",
"ResultsThere",
"MethodsWe",
"differences",
"months",
"outcomes",
"effect",
"study",
"function",
"Doppler",
"changes",
"period",
"events",
"analysis",
"mechanism",
"characteristics",
"purpose",
"addition",
"-E",
"fraction",
"results",
"parameters",
"velocity"
],
"name": "Effect of Tofogliflozin on Systolic and Diastolic Cardiac Function in Type 2 Diabetic Patients",
"pagination": "435-442",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1118091071"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s10557-019-06892-y"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"31321581"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s10557-019-06892-y",
"https://app.dimensions.ai/details/publication/pub.1118091071"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-10T10:20",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_799.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s10557-019-06892-y"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10557-019-06892-y'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10557-019-06892-y'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10557-019-06892-y'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10557-019-06892-y'
This table displays all metadata directly associated to this object as RDF triples.
289 TRIPLES
22 PREDICATES
119 URIs
102 LITERALS
19 BLANK NODES